| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 16 | 2025 | 877 | 3.080 |
Why?
|
| Hypertension | 27 | 2021 | 1352 | 2.160 |
Why?
|
| Antihypertensive Agents | 13 | 2021 | 414 | 1.570 |
Why?
|
| Primary Health Care | 15 | 2017 | 770 | 1.530 |
Why?
|
| Cognition Disorders | 6 | 2019 | 552 | 1.070 |
Why?
|
| Cognition | 9 | 2025 | 819 | 1.060 |
Why?
|
| Cognitive Dysfunction | 7 | 2025 | 336 | 1.020 |
Why?
|
| Cognitive Reserve | 1 | 2025 | 5 | 0.930 |
Why?
|
| tau Proteins | 2 | 2025 | 258 | 0.800 |
Why?
|
| Neuropsychological Tests | 9 | 2024 | 952 | 0.770 |
Why?
|
| Computer Communication Networks | 1 | 2022 | 17 | 0.710 |
Why?
|
| International Cooperation | 1 | 2022 | 161 | 0.670 |
Why?
|
| Blood Pressure | 8 | 2021 | 1344 | 0.650 |
Why?
|
| Dementia | 5 | 2025 | 435 | 0.610 |
Why?
|
| Medication Adherence | 4 | 2021 | 336 | 0.610 |
Why?
|
| Aged | 36 | 2025 | 20818 | 0.580 |
Why?
|
| Disease Progression | 4 | 2021 | 2190 | 0.560 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2023 | 1262 | 0.560 |
Why?
|
| Caregivers | 1 | 2023 | 589 | 0.520 |
Why?
|
| Brain | 3 | 2025 | 3147 | 0.510 |
Why?
|
| Patient Compliance | 5 | 2014 | 463 | 0.460 |
Why?
|
| Drug Resistance | 2 | 2014 | 242 | 0.430 |
Why?
|
| Vestibular Function Tests | 1 | 2014 | 34 | 0.420 |
Why?
|
| Cohort Studies | 7 | 2025 | 5047 | 0.410 |
Why?
|
| Middle Aged | 43 | 2025 | 28315 | 0.410 |
Why?
|
| Office Visits | 1 | 2014 | 80 | 0.410 |
Why?
|
| Humans | 77 | 2025 | 130204 | 0.400 |
Why?
|
| Community Networks | 1 | 2013 | 30 | 0.400 |
Why?
|
| Male | 58 | 2025 | 64425 | 0.400 |
Why?
|
| Vestibular Diseases | 1 | 2014 | 67 | 0.390 |
Why?
|
| Patient Education as Topic | 4 | 2016 | 461 | 0.390 |
Why?
|
| Mental Recall | 1 | 2014 | 136 | 0.390 |
Why?
|
| Cyclobutanes | 1 | 2013 | 6 | 0.390 |
Why?
|
| Appetite Depressants | 1 | 2013 | 23 | 0.380 |
Why?
|
| Health Services Research | 2 | 2013 | 180 | 0.370 |
Why?
|
| Ceramides | 1 | 2012 | 47 | 0.360 |
Why?
|
| Female | 55 | 2025 | 70342 | 0.360 |
Why?
|
| Life Style | 6 | 2025 | 450 | 0.350 |
Why?
|
| Delivery of Health Care | 3 | 2016 | 683 | 0.340 |
Why?
|
| Weight Loss | 2 | 2013 | 535 | 0.330 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 462 | 0.320 |
Why?
|
| Aged, 80 and over | 15 | 2024 | 6764 | 0.310 |
Why?
|
| Vitamin E | 1 | 2009 | 62 | 0.300 |
Why?
|
| Amyloid beta-Peptides | 3 | 2025 | 230 | 0.290 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 2 | 2022 | 11 | 0.290 |
Why?
|
| Elder Abuse | 4 | 2002 | 25 | 0.290 |
Why?
|
| Education | 2 | 2006 | 112 | 0.280 |
Why?
|
| Electronic Health Records | 3 | 2016 | 834 | 0.280 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 293 | 0.280 |
Why?
|
| Texas | 16 | 2016 | 3655 | 0.270 |
Why?
|
| Insulin | 2 | 2013 | 1146 | 0.270 |
Why?
|
| Vaccination | 4 | 2017 | 1054 | 0.270 |
Why?
|
| Adult | 32 | 2018 | 31035 | 0.270 |
Why?
|
| Antioxidants | 1 | 2009 | 331 | 0.260 |
Why?
|
| Positron-Emission Tomography | 2 | 2025 | 283 | 0.250 |
Why?
|
| Cardiovascular Diseases | 6 | 2024 | 2108 | 0.250 |
Why?
|
| Intelligence Tests | 1 | 2006 | 61 | 0.240 |
Why?
|
| Immunization Programs | 2 | 2017 | 68 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2006 | 1456 | 0.240 |
Why?
|
| Educational Status | 2 | 2025 | 276 | 0.240 |
Why?
|
| Physicians | 2 | 2011 | 626 | 0.240 |
Why?
|
| Intelligence | 1 | 2006 | 101 | 0.230 |
Why?
|
| Entorhinal Cortex | 1 | 2025 | 28 | 0.230 |
Why?
|
| Healthy Aging | 1 | 2025 | 13 | 0.230 |
Why?
|
| Obesity | 4 | 2013 | 2401 | 0.220 |
Why?
|
| Patient Participation | 1 | 2007 | 252 | 0.220 |
Why?
|
| Decision Support Techniques | 1 | 2007 | 292 | 0.210 |
Why?
|
| United States | 12 | 2025 | 11959 | 0.210 |
Why?
|
| Risk Reduction Behavior | 1 | 2025 | 143 | 0.210 |
Why?
|
| Amnesia | 1 | 2024 | 20 | 0.200 |
Why?
|
| Parietal Lobe | 1 | 2024 | 46 | 0.200 |
Why?
|
| Genetic Loci | 1 | 2025 | 353 | 0.200 |
Why?
|
| Biomarkers | 5 | 2024 | 3358 | 0.200 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 700 | 0.200 |
Why?
|
| Markov Chains | 1 | 2023 | 101 | 0.190 |
Why?
|
| Chest Pain | 1 | 2004 | 121 | 0.190 |
Why?
|
| Health Promotion | 2 | 2016 | 418 | 0.190 |
Why?
|
| Exercise Test | 1 | 2004 | 239 | 0.190 |
Why?
|
| Mood Disorders | 1 | 2004 | 129 | 0.190 |
Why?
|
| Cohort Effect | 2 | 2019 | 5 | 0.190 |
Why?
|
| Databases, Factual | 3 | 2011 | 1232 | 0.180 |
Why?
|
| Risk Factors | 16 | 2025 | 10967 | 0.180 |
Why?
|
| Observational Studies as Topic | 1 | 2022 | 102 | 0.170 |
Why?
|
| Self Efficacy | 2 | 2013 | 209 | 0.170 |
Why?
|
| Physician's Role | 1 | 2003 | 164 | 0.170 |
Why?
|
| Mortality | 1 | 2003 | 264 | 0.170 |
Why?
|
| Blood Pressure Determination | 4 | 2011 | 118 | 0.170 |
Why?
|
| Prostatic Neoplasms | 2 | 2007 | 1406 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 1283 | 0.160 |
Why?
|
| Health Services for the Aged | 1 | 2001 | 33 | 0.160 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1483 | 0.160 |
Why?
|
| Cholinergic Neurons | 1 | 2020 | 21 | 0.160 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2020 | 52 | 0.160 |
Why?
|
| Influenza, Human | 2 | 2017 | 704 | 0.160 |
Why?
|
| Cerebellum | 1 | 2024 | 441 | 0.150 |
Why?
|
| Regression Analysis | 5 | 2016 | 760 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3742 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2025 | 3406 | 0.150 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 185 | 0.150 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 2290 | 0.150 |
Why?
|
| Health Surveys | 3 | 2013 | 261 | 0.140 |
Why?
|
| Health Behavior | 3 | 2012 | 386 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 5166 | 0.140 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 3 | 2013 | 52 | 0.140 |
Why?
|
| Physician-Patient Relations | 2 | 2014 | 439 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2020 | 688 | 0.130 |
Why?
|
| Genome-Wide Association Study | 1 | 2025 | 1828 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 316 | 0.130 |
Why?
|
| Mass Screening | 3 | 2014 | 819 | 0.130 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1999 | 168 | 0.130 |
Why?
|
| Diphtheria-Tetanus Vaccine | 1 | 2016 | 3 | 0.120 |
Why?
|
| Anxiety | 1 | 2023 | 1007 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2000 | 643 | 0.120 |
Why?
|
| Exercise | 5 | 2025 | 882 | 0.120 |
Why?
|
| Ambulatory Care Facilities | 2 | 2007 | 231 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2016 | 783 | 0.120 |
Why?
|
| Linear Models | 3 | 2011 | 687 | 0.120 |
Why?
|
| Telephone | 1 | 1996 | 110 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 890 | 0.120 |
Why?
|
| Immunization | 1 | 2017 | 269 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 115 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2014 | 1241 | 0.110 |
Why?
|
| Logistic Models | 5 | 2004 | 1797 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 371 | 0.110 |
Why?
|
| Pneumococcal Vaccines | 1 | 2016 | 174 | 0.110 |
Why?
|
| New York | 1 | 2015 | 69 | 0.110 |
Why?
|
| Dizziness | 1 | 2014 | 29 | 0.110 |
Why?
|
| Activities of Daily Living | 3 | 2022 | 386 | 0.100 |
Why?
|
| Education, Medical | 2 | 2003 | 289 | 0.100 |
Why?
|
| Minority Groups | 3 | 1993 | 259 | 0.100 |
Why?
|
| Prevalence | 6 | 2004 | 2691 | 0.100 |
Why?
|
| White Coat Hypertension | 1 | 2013 | 10 | 0.100 |
Why?
|
| Diabetes Mellitus | 3 | 2013 | 888 | 0.100 |
Why?
|
| Physical Examination | 1 | 2014 | 166 | 0.100 |
Why?
|
| Education, Premedical | 2 | 1991 | 2 | 0.100 |
Why?
|
| Alcoholics Anonymous | 1 | 2013 | 3 | 0.100 |
Why?
|
| Temperance | 1 | 2013 | 15 | 0.100 |
Why?
|
| Self-Help Groups | 1 | 2013 | 14 | 0.100 |
Why?
|
| Health Literacy | 1 | 2014 | 77 | 0.100 |
Why?
|
| Postural Balance | 1 | 2014 | 134 | 0.100 |
Why?
|
| Religion and Medicine | 1 | 2013 | 26 | 0.100 |
Why?
|
| Biostatistics | 1 | 2012 | 10 | 0.090 |
Why?
|
| Motivation | 3 | 2016 | 328 | 0.090 |
Why?
|
| Smoking Cessation | 2 | 2012 | 189 | 0.090 |
Why?
|
| Systole | 3 | 2011 | 195 | 0.090 |
Why?
|
| Patient Selection | 1 | 1996 | 724 | 0.090 |
Why?
|
| Spirituality | 1 | 2013 | 49 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 222 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2025 | 12824 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2014 | 553 | 0.090 |
Why?
|
| Internal Medicine | 3 | 2016 | 124 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2016 | 503 | 0.090 |
Why?
|
| Young Adult | 3 | 2018 | 10000 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 882 | 0.080 |
Why?
|
| Epilepsy | 1 | 2018 | 865 | 0.080 |
Why?
|
| Sphingomyelins | 1 | 2011 | 16 | 0.080 |
Why?
|
| Analysis of Variance | 4 | 2011 | 928 | 0.080 |
Why?
|
| Uncertainty | 1 | 2011 | 95 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2017 | 712 | 0.080 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 236 | 0.080 |
Why?
|
| Self Report | 1 | 2014 | 553 | 0.080 |
Why?
|
| Alcoholism | 1 | 2013 | 244 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 187 | 0.080 |
Why?
|
| Emigration and Immigration | 2 | 2001 | 80 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2014 | 710 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2013 | 3798 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2007 | 909 | 0.080 |
Why?
|
| Surveys and Questionnaires | 7 | 2018 | 4036 | 0.080 |
Why?
|
| Body Mass Index | 5 | 2007 | 1694 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2009 | 1481 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 496 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 776 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2009 | 483 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2013 | 3351 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2022 | 17577 | 0.060 |
Why?
|
| Survival | 1 | 2006 | 16 | 0.060 |
Why?
|
| Pennsylvania | 2 | 2016 | 60 | 0.060 |
Why?
|
| Community Health Centers | 3 | 2003 | 35 | 0.060 |
Why?
|
| Relief Work | 1 | 2006 | 29 | 0.060 |
Why?
|
| Anthropometry | 2 | 2004 | 187 | 0.060 |
Why?
|
| Diuretics | 2 | 2013 | 157 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2021 | 6407 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2003 | 1394 | 0.060 |
Why?
|
| Social Participation | 1 | 2025 | 12 | 0.060 |
Why?
|
| Counseling | 1 | 2007 | 236 | 0.060 |
Why?
|
| Geriatrics | 2 | 2006 | 74 | 0.060 |
Why?
|
| Motor Activity | 2 | 2007 | 488 | 0.060 |
Why?
|
| Disasters | 1 | 2006 | 101 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2025 | 232 | 0.050 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 51 | 0.050 |
Why?
|
| Chi-Square Distribution | 4 | 2011 | 563 | 0.050 |
Why?
|
| GTP-Binding Proteins | 2 | 2002 | 156 | 0.050 |
Why?
|
| Reaction Time | 1 | 2004 | 150 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 108 | 0.050 |
Why?
|
| Visual Perception | 1 | 2004 | 127 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 172 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2004 | 137 | 0.050 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2003 | 72 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2006 | 829 | 0.050 |
Why?
|
| Specialization | 1 | 2003 | 75 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2004 | 905 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 352 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2003 | 80 | 0.050 |
Why?
|
| Medicine | 1 | 2003 | 99 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2024 | 270 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2009 | 3679 | 0.040 |
Why?
|
| Blood Glucose | 3 | 2001 | 1112 | 0.040 |
Why?
|
| Family Practice | 2 | 2016 | 82 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 340 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2024 | 381 | 0.040 |
Why?
|
| Program Evaluation | 3 | 2016 | 443 | 0.040 |
Why?
|
| Learning | 1 | 2004 | 353 | 0.040 |
Why?
|
| Prejudice | 1 | 2001 | 39 | 0.040 |
Why?
|
| Geriatric Assessment | 2 | 2000 | 183 | 0.040 |
Why?
|
| Awareness | 1 | 2001 | 78 | 0.040 |
Why?
|
| Sampling Studies | 2 | 2001 | 76 | 0.040 |
Why?
|
| Syndrome | 1 | 2004 | 1156 | 0.040 |
Why?
|
| Lipids | 1 | 2004 | 566 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2004 | 366 | 0.040 |
Why?
|
| Incidence | 2 | 2001 | 3329 | 0.040 |
Why?
|
| Acute Disease | 1 | 2004 | 1153 | 0.040 |
Why?
|
| Cause of Death | 1 | 2003 | 502 | 0.040 |
Why?
|
| Genotype | 2 | 2020 | 2588 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 1376 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2001 | 146 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2001 | 120 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 148 | 0.040 |
Why?
|
| Phenotype | 2 | 2020 | 4454 | 0.040 |
Why?
|
| Cholinergic Antagonists | 1 | 2020 | 46 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 411 | 0.040 |
Why?
|
| Glycogen | 1 | 1999 | 51 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2001 | 331 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 1166 | 0.040 |
Why?
|
| American Heart Association | 1 | 2021 | 338 | 0.040 |
Why?
|
| Smoking | 1 | 2004 | 930 | 0.040 |
Why?
|
| Postprandial Period | 1 | 1999 | 90 | 0.040 |
Why?
|
| Social Work | 1 | 1999 | 22 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2000 | 214 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2000 | 216 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2020 | 435 | 0.040 |
Why?
|
| Hyperglycemia | 2 | 1999 | 233 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 729 | 0.040 |
Why?
|
| Urban Population | 2 | 1998 | 284 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2020 | 300 | 0.030 |
Why?
|
| Triglycerides | 1 | 2001 | 603 | 0.030 |
Why?
|
| Cholesterol | 1 | 2001 | 537 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 511 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 240 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2012 | 455 | 0.030 |
Why?
|
| Social Support | 2 | 2012 | 369 | 0.030 |
Why?
|
| Hippocampus | 1 | 2022 | 794 | 0.030 |
Why?
|
| Age of Onset | 2 | 2011 | 592 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 703 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 1996 | 52 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2016 | 80 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2827 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 236 | 0.030 |
Why?
|
| Random Allocation | 1 | 1996 | 409 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2553 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1674 | 0.030 |
Why?
|
| Urban Health | 2 | 2012 | 83 | 0.030 |
Why?
|
| Aging | 1 | 2003 | 1238 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 1996 | 222 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 1214 | 0.030 |
Why?
|
| Glucose | 1 | 1999 | 851 | 0.030 |
Why?
|
| Age Factors | 1 | 2001 | 2824 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1999 | 558 | 0.030 |
Why?
|
| Foot Diseases | 1 | 1993 | 20 | 0.020 |
Why?
|
| Protestantism | 1 | 2013 | 4 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 107 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2003 | 1217 | 0.020 |
Why?
|
| Poverty | 2 | 2012 | 461 | 0.020 |
Why?
|
| Amlodipine | 1 | 2012 | 21 | 0.020 |
Why?
|
| Chlorthalidone | 1 | 2012 | 25 | 0.020 |
Why?
|
| Sex Factors | 2 | 2000 | 1345 | 0.020 |
Why?
|
| Lisinopril | 1 | 2012 | 27 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2012 | 56 | 0.020 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2012 | 13 | 0.020 |
Why?
|
| Eye Diseases | 1 | 1993 | 106 | 0.020 |
Why?
|
| College Admission Test | 1 | 1991 | 6 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2012 | 94 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 218 | 0.020 |
Why?
|
| Attitude to Health | 1 | 1992 | 246 | 0.020 |
Why?
|
| Korea | 1 | 2011 | 32 | 0.020 |
Why?
|
| Diastole | 1 | 2011 | 181 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 241 | 0.020 |
Why?
|
| Depression | 1 | 2000 | 1315 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 413 | 0.020 |
Why?
|
| Africa | 2 | 2001 | 135 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1604 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1992 | 401 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2012 | 627 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1205 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2007 | 43 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2007 | 31 | 0.020 |
Why?
|
| Cotinine | 1 | 2007 | 25 | 0.020 |
Why?
|
| Group Processes | 1 | 2007 | 48 | 0.020 |
Why?
|
| Health Facility Environment | 1 | 2006 | 8 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2007 | 91 | 0.020 |
Why?
|
| Public Health Practice | 1 | 2006 | 20 | 0.020 |
Why?
|
| Sodium | 1 | 2007 | 280 | 0.010 |
Why?
|
| Focus Groups | 1 | 2007 | 239 | 0.010 |
Why?
|
| Triage | 1 | 2006 | 144 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 997 | 0.010 |
Why?
|
| Radiology | 1 | 2006 | 119 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2003 | 109 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13298 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2006 | 284 | 0.010 |
Why?
|
| Body Weight | 1 | 2007 | 986 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 15015 | 0.010 |
Why?
|
| Adolescent | 2 | 2018 | 20816 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2007 | 710 | 0.010 |
Why?
|
| Angiotensinogen | 1 | 2001 | 24 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2001 | 56 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1984 | 342 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2001 | 239 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 2105 | 0.010 |
Why?
|
| Students, Medical | 1 | 1984 | 346 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2000 | 270 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2000 | 111 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1999 | 227 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 3030 | 0.010 |
Why?
|
| Heart Failure | 1 | 2012 | 2325 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 1999 | 93 | 0.010 |
Why?
|
| Lactic Acid | 1 | 1999 | 145 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1999 | 198 | 0.010 |
Why?
|
| Mandatory Reporting | 1 | 1999 | 22 | 0.010 |
Why?
|
| Mexican Americans | 1 | 1999 | 162 | 0.010 |
Why?
|
| Child | 1 | 2018 | 26194 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 1087 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 1669 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2000 | 1210 | 0.010 |
Why?
|
| Pediatrics | 1 | 2006 | 1243 | 0.010 |
Why?
|
| Reference Values | 1 | 1996 | 674 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1999 | 804 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2001 | 1104 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6166 | 0.010 |
Why?
|
| Cost Savings | 1 | 1993 | 79 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1993 | 86 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 1993 | 129 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1993 | 197 | 0.010 |
Why?
|
| Health Education | 1 | 1993 | 226 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1996 | 2891 | 0.000 |
Why?
|